Mon – Sat: 9:00 AM – 7:00 PM IST
CRM

What is RCPA in pharma CRM?

The retail chemist prescription audit — what medical representatives actually collect, and why the data is so easily corrupted.

In short

RCPA stands for Retail Chemist Prescription Audit. A medical representative visits a chemist near a doctor's clinic and records which products are moving, in what quantity, and from which competing brands. It is the field's only direct evidence of whether a doctor's stated prescribing behaviour matches what is actually being dispensed.

Why It Matters

Why this matters in practice

RCPA is the closest a pharmaceutical field force gets to ground truth. A doctor may say they are prescribing your product; the chemist's movement tells you whether that is so. The weakness is that the data is self-reported by the person whose performance it reflects, which makes capture design and validation more important than in almost any other field-sales process.

Direct evidence of dispensing rather than stated intent
Reveals competitor share at the point of dispensing
Links a doctor's claimed support to actual movement
Feeds territory planning and product focus decisions
How It Works

How it works in practice

1

Chemist mapping

Chemists are linked to the doctors whose prescriptions they are likely to fill. Without this link the data has no interpretation.

2

Structured capture

Product, competitor brand, quantity and period, from a pick list rather than free text, so the data aggregates.

3

Visit context

Captured during the chemist visit, with date and location, so it can be validated against the beat plan.

4

Validation

Outliers and implausible entries flagged for review. Unchecked self-reported data degrades quickly.

5

Analysis

Share of movement by territory and product, compared against the doctor call plan to see where effort is converting.

Worked example

A worked example: what the audit actually reveals

A medical representative covers a doctor who claims to prescribe the company's brand regularly. Sales in the territory are flat, and the representative has no way to reconcile the two.

An RCPA at the three chemists nearest that clinic shows the molecule moving around 180 units a month, of which the company's brand accounts for 22 and a competitor for 140. The doctor is prescribing the molecule heavily and the brand rarely. That is a completely different conversation from the one the representative was preparing — it is not about convincing the doctor the molecule works, it is about why another brand is winning within it.

Used this way, RCPA converts a vague call into a specific one with evidence behind it. Used badly, it becomes a data-entry obligation where representatives record plausible numbers to close the form. The difference is whether anyone acts on the output: audits that feed into call planning and brand strategy get filled in honestly, and audits that disappear into a report nobody opens get filled in quickly.

Key terms

The vocabulary, briefly

Term What it means
RCPA Retail Chemist Prescription Audit — sampling chemist sales to infer prescribing behaviour.
Prescriber The doctor whose prescriptions drive demand, though they never buy the product.
Brand share Your product's share of sales in a molecule category at a given outlet.
Competitor conversion Shifting prescriptions from a competing brand to yours, which is what RCPA is for.
Chemist universe The mapped set of outlets around a prescriber, defining where their prescriptions land.
What Goes Wrong

Common mistakes worth avoiding

Free-text product entry

Makes aggregation impossible and invites inconsistency. Use a controlled product and brand list.

No validation of outliers

Self-reported data without checks drifts toward whatever reflects well on the reporter.

Capturing without linking to doctors

RCPA that is not tied to the prescribing doctors it relates to produces numbers with no action attached.

Too many fields

A long form during a chemist visit gets completed later from memory, which defeats the purpose.

What to measure

Numbers worth tracking

Metric What it tells you What distorts it
Brand share by outlet Where you are winning and losing within the molecule, outlet by outlet.
RCPA coverage Share of key outlets audited in the period. Thin coverage makes the inference unreliable.
Prescription trend after a call Whether calls actually move behaviour, measured over the following weeks.
Competitor movement Which rival is gaining, which is the input to brand strategy rather than to call planning.
FAQ

Questions we are asked about this

Commonly on a defined cycle per territory, aligned to the beat plan, rather than opportunistically. Consistency of interval matters more than frequency for trend analysis.
Only with design and validation. Structured capture, geotagged visits, plausibility checks and periodic supervisor verification are what make it usable.
Monthly for key outlets around high-potential prescribers, quarterly for the broader territory. More frequently than monthly produces noise rather than signal, because prescription patterns do not move that fast and the sampling error dominates. Less frequently than quarterly and you are reacting to changes long after a competitor made them.
It is a sample, with the limitations that implies. Chemists may not share accurate figures, patients fill prescriptions at outlets you did not audit, and the representative collecting the data has an interest in how it looks. Treat it as directional evidence rather than measurement — the useful signal is a change in share over time at the same outlets, which is far more robust than any single month's absolute numbers.
RCPA data belongs against the prescriber and the outlet, linked to call history, so a representative preparing for a visit sees prescribing inference and call record together. Where it genuinely pays is in call planning: representatives should spend time proportional to opportunity, and opportunity is molecule volume multiplied by the share you do not yet have. Without RCPA that allocation is based on who is pleasant to visit.
Yes, and they vary by jurisdiction and have tightened considerably. Pharmaceutical marketing is governed by codes covering interactions with healthcare professionals, and data collection involving patient-level information attracts privacy obligations. RCPA at the aggregate outlet level is standard industry practice, but anything approaching individual patient data is a different matter. Take compliance advice on your specific practice rather than assuming the industry norm is the legal position.
Related

Where to read next

Our ePharma Sales CRM

Read more

What is sales-force automation?

Read more

CRM vs ERP

Read more

Need this applied to your own systems?

We build and support the systems this page describes. Start with a free working proof of concept — no cost, no commitment.